Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2025-12-24 @ 10:57 PM
NCT ID:
NCT06231069
Eligibility Criteria:
Inclusion Criteria:
* non-smoking
* non-diabetic
* apparently healthy
* minimally recreationally active
* males and females aged 18-30 years
Exclusion Criteria:
* pregnancy
* breast feeding
* smoking
* obesity
* diabetes mellitus
* cardiovascular disease (recent myocardial infarction (≤ 6 months)
* hypertension requiring more than 2 medications
* congestive heart failure requiring more than one medication,
* renal disease (creatinine \> 130),
* previous stroke with residual hemiparesis,
* active musculoskeletal injuries and/or severe osteoarthritis,
* significant weight loss in the 3-month period prior to the study,
* vegan diet,
* dairy protein allergy,
* muscular dystrophy,
* severe peripheral neuropathy,
* severe osteoporosis,
* use of medications known to affect protein metabolism (i.e. corticosteroids),
* inability to consent,
* chronic obstructive pulmonary disease (FVC or FEV1 \< 70% of age predicted mean value),
* asthma requiring more than two medications.
* Subjects on supplements will be considered on a case-by-case basis, but they will be asked to refrain from intake for at least 2 weeks prior to partaking in this study.
* While adverse events are not anticipated, participants will be asked to disclose if they are using supplements that may have negative/interactive effects with our study products. Each participant's list of medications will also be checked for potential interactive side-effects with our supplements; however, the individual doses have specifically been chosen to be at the low end to minimize the likelihood of such interactions.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
30 Years
Study:
NCT06231069
Study Brief:
Protocol Section:
NCT06231069